ABT vs XTIA · P/E 25, rev $44.33B vs rev $3.2M
Abbott Laboratories (ABT) versus XTI Aerospace, Inc. (XTIA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
XTI Aerospace, Inc. (XTIA) is a aerospace & defense company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported XTIA revenue for 2024-12-31 was $3.2M. Net income was -$35.6M. Revenue was down 29.8% from 2023-12-31 to 2024-12-31. XTIA currently screens at market cap $69.3M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. XTIA currently screens at market cap $69.3M.
Not investment advice. Open the ABT and XTIA stock pages for the full models.
Not investment advice.